The Story of How Horizon Pharma Creatively Scaled

The Story of How Horizon Pharma Creatively Scaled

In the world of finance and stocks, there are times when “the stars line up” to create an especially interesting story. Such was the case when the announcement was made in March that Chicago-area Horizon Pharma Inc. was joining forces with privately held Vidara Therapeutics (a company which is listed as being headquartered in Roswell, → Read More

How Bad Is The Market Right Now?

How Bad Is The Market Right Now?

How bad is the market? Every trader and investor who pays attention to the markets is trying to answer that question right now. Since the beginning of the year, Goldman Sachs (GS) is down 15.5%, Amazon.com (AMZN) is down 23.6%, and Staples (SPLS) is down 25.7%. But before concluding a bear market has begun, consider → Read More

Raise or Fold?

Raise or Fold?

Draw an trendline on the S&P 500 chart from the November 2012 low and it happens to currently coincide with the big round-number 1800 level. With no other support levels nearby, 1800 will be an important psychological level for the S&P. Unless a new wave of optimism blows in, the magic 1800 level will attract → Read More

Getting Out In Time

Getting Out In Time

In Friday’s Seasonal Forecaster newsletter (4/4/2014), I pointed out one of our best stocks of the past several months had changed in character. Covance (CVD) had twice tried to break to new highs, and both times it immediately broke down on high volume. Compared to the past year where most above-average volume days were on → Read More

How High Can Mountains Be?

How High Can Mountains Be?

How High Can Mountains Be? All of a sudden, answering this question became a big concern with me. Thursday evenings seem to be fertile ground for these types of questions (along with the other six days). Is there a maximum limit to the height of mountains? Unsurprisingly, this question has been asked before. A web search → Read More

What is Pullback Smoothness?

What is Pullback Smoothness?

There is one technical analysis technique I use that you won’t find in any book. I don’t even have a term for it – maybe ‘pullback smoothness’, or something like that. I have noticed over the years that stocks that pull back forming a ‘smoothly’ falling Stochastics tend to rebound cleanly. By this I mean → Read More

Time for an Inverse ETF Trade?

Time for an Inverse ETF Trade?

Inverse ETFs I see too much risk and not enough gain in various bearish trades I’ve been looking at. Sure, I look at many charts and see textbook bearish setups. So this environment must be ripe for bear put spreads, long puts, and short stock trades, right? But with the money that keeps coming back → Read More

Seasonal Analysis = 25% gain in 31 Days

Seasonal Analysis = 25% gain in 31 Days

The February 19th, 2014 Seasonal Forecaster newsletter introduced readers to a stock not often mentioned on the financial press. “Ann Inc, a women’s apparel chain, has good fundamentals (an EPS growth rate of 43% and a Return On Equity of 26%). My interest in this stock is it has a very strong seasonal right now. → Read More

Did You Solve The Puzzle?

Did You Solve The Puzzle?

On March 7th, I presented a puzzle. I showed a stock with a high probability rebound pattern: I showed how the stock has been steadily increasing revenues as well as earnings: I showed an ROE that institutions love: The number of funds holding this stock has been steadily increasing: I detailed insider buying: “On December → Read More

Goldman Sachs (GS) Offering Possible 8.81% Return Over the Next 30 Calendar Days

Goldman Sachs (GS) Offering Possible 8.81% Return Over the Next 30 Calendar Days

Goldman Sachs’s most recent trend suggests a bullish bias. One trading opportunity on Goldman Sachs is a Bull Put Spread using a strike $160.00 short put and a strike $150.00 long put offers a potential 8.81% return on risk over the next 30 calendar days. Maximum profit would be generated if the Bull Put Spread → Read More


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.